找回密碼
 To register

QQ登錄

只需一步，快速開(kāi)始

掃一掃，訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Hematopoietic Growth Factors in Oncology; Gary H. Lyman,David C. Dale Book 2011 Springer Science+Business Media, LLC 2011 Biology.Molecula

[復(fù)制鏈接]
查看: 14168|回復(fù): 58
樓主
發(fā)表于 2025-3-21 17:53:41 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology
編輯Gary H. Lyman,David C. Dale
視頻videohttp://file.papertrans.cn/426/425562/425562.mp4
概述Illustrates the progress resulted from advances in our understanding of cellular and molecular biology, genetic engineering and the development of more effective yet often more toxic cancer treatments
叢書(shū)名稱(chēng)Cancer Treatment and Research
圖書(shū)封面Titlebook: Hematopoietic Growth Factors in Oncology; Gary H. Lyman,David C. Dale Book 2011 Springer Science+Business Media, LLC 2011 Biology.Molecula
描述.Progress in the treatment of cancer over the past two decades has been rapid with many new and novel therapeutic modalities arriving at an unprecedented pace. Overall cancer mortality rates have actually begun to fall in parallel with progress in the diagnosis and treatment of malignant disease. Despite our advances in the understanding of the biology and molecular genetics of cancer, as well as the availability of an increasing array of effective therapies, cancer treatment today and for the foreseeable future will include the traditional modalities of surgery, radiation therapy and chemotherapy. Myelosuppressive agents with their potential hematopoietic toxicities remain the mainstay of systemic treatment for both metastatic and early stage cancer. The complications of cancer chemotherapy have serious impact on a patient’s well being and overall quality of life. Fortunately, advances in cancer treatment have been accompanied by equally impressive progress in the availability of a wide array of supportive care modalities which have greatly enhanced the ability of oncologists to minimize the impact of cancer and its treatment on patient quality of life as well improve delivery of
出版日期Book 2011
關(guān)鍵詞Biology; Molecular Genetics; Pharmacology
版次1
doihttps://doi.org/10.1007/978-1-4419-7073-2
isbn_softcover978-1-4614-2728-5
isbn_ebook978-1-4419-7073-2Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightSpringer Science+Business Media, LLC 2011
The information of publication is updating

書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology影響因子(影響力)




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology被引頻次




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology被引頻次學(xué)科排名




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology年度引用




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology年度引用學(xué)科排名




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology讀者反饋




書(shū)目名稱(chēng)Hematopoietic Growth Factors in Oncology讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics
 

0票 0.00%

Better Implies Difficulty
 

1票 100.00%

Good and Satisfactory
 

0票 0.00%

Adverse Performance
 

0票 0.00%

Disdainful Garbage
您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:08:43 | 只看該作者
Summary and Comparison of Myeloid Growth Factor Guidelines in Patients Receiving Cancer Chemotherapyreceiving regimens associated with lower risk should have CSF use guided by individual risk assessment. Critical quality appraisal indicates that the scope and purpose, stakeholder involvement, and applicability of the guidelines differ little. There is more emphasis on comprehensive literature revi
板凳
發(fā)表于 2025-3-22 00:23:53 | 只看該作者
地板
發(fā)表于 2025-3-22 06:37:01 | 只看該作者
Ten Years of Meta-analyses on Erythropoiesis-Stimulating Agents in Cancer Patients thrombovascular events. An increased risk of thrombovascular events was observed in all but two meta-analyses (relative risks (RRs) ranging from 1.57 to 1.69). However, potential reporting and publication bias as well as detection bias call for a cautious interpretation of these results. Survival a
5#
發(fā)表于 2025-3-22 09:41:24 | 只看該作者
Book 2011in cancer treatment have been accompanied by equally impressive progress in the availability of a wide array of supportive care modalities which have greatly enhanced the ability of oncologists to minimize the impact of cancer and its treatment on patient quality of life as well improve delivery of
6#
發(fā)表于 2025-3-22 16:35:24 | 只看該作者
Gary H. Lyman,Nicole M. Kuderere June 1-10, 1987, at the same location. At the plenary session of this meeting it was decided that future meetings should have a principal theme. The theme for the third meeting (June 1- 10, 1989, Kupuri) was Karamata‘s Regular Variation. The principal theme for the fourth meeting (June 1-10, 1990,
7#
發(fā)表于 2025-3-22 20:50:42 | 只看該作者
8#
發(fā)表于 2025-3-22 22:49:19 | 只看該作者
0927-3042 ty of a wide array of supportive care modalities which have greatly enhanced the ability of oncologists to minimize the impact of cancer and its treatment on patient quality of life as well improve delivery of 978-1-4614-2728-5978-1-4419-7073-2Series ISSN 0927-3042 Series E-ISSN 2509-8497
9#
發(fā)表于 2025-3-23 02:34:44 | 只看該作者
10#
發(fā)表于 2025-3-23 08:00:11 | 只看該作者
Early-Acting Hematopoietic Growth Factors: Biology and Clinical Experiencet biologically interesting molecules and at least theoretically have diverse applications in the evolving field of regenerative medicine. Among this class of regulators, the early-acting hematopoietic growth factors and their cellular targets are perhaps the best characterized and serve as a paradig
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 06:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
赤水市| 临沂市| 山阴县| 万年县| 舒兰市| 宿迁市| 常宁市| 思南县| 长乐市| 肇州县| 阿拉善盟| 嘉兴市| 五寨县| 石景山区| 长治市| 亚东县| 镇平县| 天镇县| 永城市| 长治市| 武鸣县| 繁昌县| 泾川县| 尼玛县| 郓城县| 阿克陶县| 元江| 泰安市| 阿尔山市| 仙桃市| 镇安县| 团风县| 光山县| 平山县| 谷城县| 扶风县| 晋城| 溧阳市| 米泉市| 双辽市| 巴彦淖尔市|